Compositions and Methods of Inhibiting MASP-2 for the Treatment of Various Thrombotic Diseases and Disorders
US-2026062499-A1 · Mar 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Dudler Thomas patents
Dudler Thomas is listed as an inventor on 70 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dudler Thomas |
| Total patents | 70 |
| First publication | Feb 10, 2015 |
| Latest publication | Mar 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for treating conditions associated with masp-2 dependent complement activation
US-2026062498-A1 · Mar 5, 2026 · US
Methods for inhibiting fibrosis in a subject in need thereof
US-2025092157-A1 · Mar 20, 2025 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2025059299-A1 · Feb 20, 2025 · US
Methods for inhibiting angiogenesis in a subject in need thereof
US-2024352152-A1 · Oct 24, 2024 · US
Therapeutic antibodies that bind to the serine protease domain of MASP-2 and uses thereof
US-12091468-B2 · Sep 17, 2024 · US
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant
US-2024293465-A1 · Sep 5, 2024 · US
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
US-2024254257-A1 · Aug 1, 2024 · US
Methods for treating conditions associated with masp-2 dependent complement activation
US-2024228665-A1 · Jul 11, 2024 · US
Methods for inhibiting angiogenesis in a subject in need thereof
US-11981748-B2 · May 14, 2024 · US
Recent patents
Latest publications not already listed above.
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2024124611-A1 · Apr 18, 2024 · US
Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof
US-2024101709-A1 · Mar 28, 2024 · US
Compositions for inhibiting masp-2 dependent complement activation
US-2024092938-A1 · Mar 21, 2024 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2024076409-A1 · Mar 7, 2024 · US
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
US-11896621-B2 · Feb 13, 2024 · US
Methods for treating conditions associated with MASP-2 dependent complement activation
US-11884742-B2 · Jan 30, 2024 · US
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
US-11883493-B2 · Jan 30, 2024 · US
Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof
US-2023265215-A1 · Aug 24, 2023 · US
Compositions and Methods of Inhibiting MASP-2 for the Treatment of Various Thrombotic Diseases and Disorders
US-2023212314-A1 · Jul 6, 2023 · US
Compositions for inhibiting MASP-2 dependent complement activation
US-11613589-B2 · Mar 28, 2023 · US
Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome
US-11525011-B2 · Dec 13, 2022 · US
Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19
US-2022308056-A1 · Sep 29, 2022 · US
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
US-2022259325-A1 · Aug 18, 2022 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2022089781-A1 · Mar 24, 2022 · US
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
US-2022002439-A1 · Jan 6, 2022 · US
Methods for inhibiting fibrosis in a subject in need thereof
US-2021355236-A1 · Nov 18, 2021 · US
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant
US-2021290684-A1 · Sep 23, 2021 · US
Antibodies specifically binding to masp-3 for the treatment of various diseases and disorders
US-2021275667-A1 · Sep 9, 2021 · US
Methods for inhibiting angiogenesis in a subject in need thereof
US-2021189009-A1 · Jun 24, 2021 · US
Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
US-11027015-B2 · Jun 8, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Omeros Corp | 70 |
| Univ Leicester | 46 |
| Dudler Thomas | 2 |
| Demopulos Gregory A | 1 |
| Schwaeble Hans-Wilhelm | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/40 | 70 |
| C07K2317/76 | 70 |
| C07K2317/92 | 70 |
| A61K2039/505 | 70 |
| C07K2317/54 | 54 |